Related references
Note: Only part of the references are listed.Diet-induced obesity and mammary tumor development in relation to estrogen receptor status
Amitabha Ray et al.
CANCER LETTERS (2007)
Demonstration of Adiponectin Receptors 1 and 2 mRNA expression in human breast cancer cells
Chie Takahata et al.
CANCER LETTERS (2007)
Adiponectin as an anti-inflammatory factor
Noriyuki Ouchi et al.
CLINICA CHIMICA ACTA (2007)
Adiponectin in health and disease
Deborah K. Oh et al.
DIABETES OBESITY & METABOLISM (2007)
Total and high-molecular-weight adiponectin in breast cancer:: In vitro and in vivo studies
Antje Koerner et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones
G. A. Laughlin et al.
INTERNATIONAL JOURNAL OF OBESITY (2007)
Inhibition of skeletal metastasis by ectopic ERα expression in ERα-negative human breast cancer cell lines
Abhik Bandyopadhyay et al.
NEOPLASIA (2007)
Anti proliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer
J. D. Arditi et al.
HORMONE AND METABOLIC RESEARCH (2007)
Adiponectin actions in the cardiovascular system
Teresa A. Hopkins et al.
CARDIOVASCULAR RESEARCH (2007)
Adipokines as endocrine, paracrine, and autocrine factors in breast cancer risk and progression
Linda Vona-Davis et al.
ENDOCRINE-RELATED CANCER (2007)
New perspectives into the biological and clinical relevance of oestrogen receptors in the human breast
V. Speirs et al.
JOURNAL OF PATHOLOGY (2007)
Adiponectin modulates the glycogen synthase kinase-3β/β-catenin signaling pathway and attenuates mammary tumorigenesis of MDA-MB-231 cells in nude mice
Yu Wang et al.
CANCER RESEARCH (2006)
Serum ghrelin, leptin and adiponectin levels before and after weight loss: Comparisons of three methods of treatment - A prospective study
Efstathios V. Kotidis et al.
OBESITY SURGERY (2006)
Obesity and prognosis of breast cancer
A. R. Carmichael
OBESITY REVIEWS (2006)
Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells
Marie-Noelle Dieudonne et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Serum adiponectin and leptin levels in Taiwanese breast cancer patients
Da-Chung Chen et al.
CANCER LETTERS (2006)
Plasma adiponectin levels in postmenopausal women with or without long-term hormone therapy
JA Im et al.
MATURITAS (2006)
Overweight and obesity: Prevalence, consequences, and causes of a growing public health problem
SB Wyatt et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2006)
Effect of obesity on presentation of breast cancer
GA Porter et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Increased expression of leptin and the leptin receptor as a marker of breast cancer progression: Possible role of obesity-related stimuli
C Garofalo et al.
CLINICAL CANCER RESEARCH (2006)
Effect of postmenopause and hormone replacement therapy on serum adiponectin levels
L Sieminska et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2005)
Obesity and outcomes in premenopausal and postmenopausal breast cancer
S Loi et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
Adiponectin inhibits cell proliferation by interacting with several growth factors in an oligomerization-dependent manner
Y Wang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Adiponectin and adiponectin receptors
T Kadowaki et al.
ENDOCRINE REVIEWS (2005)
Adiponectin and breast cancer risk
C Mantzoros et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothelial cell apoptosis
E Bråkenhielm et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Risk factors for breast cancer in elderly women
C Sweeney et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2004)
Plasma adiponectin and leptin levels, body composition, and glucose utilization in adult women with wide ranges of age and obesity
AS Ryan et al.
DIABETES CARE (2003)
Cloning of adiponectin receptors that mediate antidiabetic metabolic effects
T Yamauchi et al.
NATURE (2003)
Genetically obese MMTV-TGF-α/LepobLepob female mice do not develop mammary tumors
MP Cleary et al.
BREAST CANCER RESEARCH AND TREATMENT (2003)
Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis
T Yamauchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States)
LM Morimoto et al.
CANCER CAUSES & CONTROL (2002)
Oligomerization state-dependent activation of NF-κB signaling pathway by adipocyte complement-related protein of 30 kDa (Acrp30)
TS Tsao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Blood growth hormone-binding protein levels in premenopausal and postmenopausal women: Roles of body weight and estrogen levels
M Bondanelli et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2001)
Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice
J Fruebis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Weight change and risk of postmenopausal breast cancer (United States)
A Trentham-Dietz et al.
CANCER CAUSES & CONTROL (2000)
Share Paper
